Alpha 2.0
Login Register
» Authors » M Cottone

M Cottone

Explore the profile of M Cottone including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 102
Citations 1943
Followers 0
Related Specialties
Gastroenterology
General Medicine
Pharmacology
Top 10 Co-Authors
A Orlando
L Pagliaro
L Oliva
E Sciarrino
A Maringhini
M Rosselli
C Cipolla
F Mocciaro
F Castiglione
F La Seta
Published In
Aliment Pharmacol Ther
Gastroenterology
Dig Liver Dis
Radiol Med
Recenti Prog Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Azathioprine for prevention of clinical recurrence in Crohn's disease patients with severe endoscopic recurrence: an IG-IBD randomized double-blind trial
Orlando A, Mocciaro F, Ventimiglia M, Renna S, Rispo A, Scribano M, et al.
Eur Rev Med Pharmacol Sci . 2020 Nov; 24(21):11356-11364. PMID: 33215456
Objective: The recurrence of Crohn's Disease after ileo-colonic resection is a crucial issue. Severe endoscopic lesions increase the risk of developing early symptoms. Prevention and treatment of post-operative Endoscopic Recurrence...
2.
Clinical course of severe colitis: a comparison between Crohn’s Disease and ulcerative colitis
Sinagra E, Orlando A, Mocciaro F, Criscuoli V, Oliva L, Maisano S, et al.
J Biol Regul Homeost Agents . 2018 Apr; 32(2):415-423. PMID: 29685027
Few data are available about the clinical course of severe colonic Crohn’s disease (CD). The aim of this study is to describe the clinical course of severe Crohn’s colitis in...
3.
Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab
Macaluso F, Orlando R, Renna S, Sapienza C, Ventimiglia M, Rizzuto G, et al.
Aliment Pharmacol Ther . 2018 Mar; 47(7):1040-1041. PMID: 29512915
No abstract available.
4.
Letter: a prospective real life comparison of the efficacy of adalimumab vs. golimumab in moderate to severe ulcerative colitis
Renna S, Orlando E, Macaluso F, Maida M, Affronti M, Giunta M, et al.
Aliment Pharmacol Ther . 2016 Jul; 44(3):310-1. PMID: 27375103
No abstract available.
5.
Letter: should HCV cirrhotics with high bilirubin or Gilbert's syndrome be excluded from paritaprevir, ombitasvir, or dasabuvir?
Madonia S, Orlando E, Stagno B, Cannizzaro M, Madonia G, Cottone M
Aliment Pharmacol Ther . 2016 Apr; 43(9):1021-2. PMID: 27040170
No abstract available.
6.
Letter: switching from one to another anti-tumour necrosis factor alpha agent, and the risks of an overlap of exposure
Macaluso F, Criscuoli V, Orlando E, Rizzuto G, Renna S, Cottone M, et al.
Aliment Pharmacol Ther . 2016 Apr; 43(9):1019-20. PMID: 27040168
No abstract available.
7.
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
Rahier J, Magro F, Abreu C, Armuzzi A, Ben-Horin S, Chowers Y, et al.
J Crohns Colitis . 2014 Mar; 8(6):443-68. PMID: 24613021
No abstract available.
8.
Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights
Sinagra E, Tomasello G, Cappello F, Leone A, Cottone M, Bellavia M, et al.
J Biol Regul Homeost Agents . 2014 Jan; 27(4):919-33. PMID: 24382173
Inflammatory bowel disease (IBD) consists of two distinct clinical forms, ulcerative colitis (UC) and Crohn's disease (CD), with unknown aetiology, which nevertheless are considered to share almost identical pathophysiological backgrounds....
9.
Systematic review: macrophage activation syndrome in inflammatory bowel disease
Fries W, Cottone M, Cascio A
Aliment Pharmacol Ther . 2013 Apr; 37(11):1033-45. PMID: 23565820
Background: Recently, there have been increasingly frequent reports on the occurrence of macrophage activation syndrome (MAS) in patients with inflammatory bowel disease (IBD). Clinically, MAS is characterized mainly by fever,...
10.
Methodological problems in RCTs on IBD
Cottone M, Criscuoli V, Modesto I, Orlando A
Rev Recent Clin Trials . 2012 Oct; 7(4):284-9. PMID: 23092230
Randomized controlled trials (RCTs) are the gold standard method for developing evidence-based medicine in inflammatory bowel disease (IBD). Methodological problems in RCTs in IBD concern different aspects such as the...